دورية أكاديمية
Role of TNF-α -308G/A Polymorphism in Bipolar Disorder and its Relationship with Clinical and Demographic Variables.
العنوان: | Role of TNF-α -308G/A Polymorphism in Bipolar Disorder and its Relationship with Clinical and Demographic Variables. |
---|---|
المؤلفون: | Akram S; Ms. Akram and Drs. Ali, Mutahir, and Saleem are with School of Biochemistry and Biotechnology, University of the Punjab in Lahore, Pakistan., Ali M; Ms. Akram and Drs. Ali, Mutahir, and Saleem are with School of Biochemistry and Biotechnology, University of the Punjab in Lahore, Pakistan., Mutahir Z; Ms. Akram and Drs. Ali, Mutahir, and Saleem are with School of Biochemistry and Biotechnology, University of the Punjab in Lahore, Pakistan., Ibad N; Dr. Ibad is with Shaikh Zayed Hospital in Lahore, Pakistan., Sarmad S; Dr. Sarmad is with Rashid Latif Medical College in Lahore, Pakistan., Mehboob S; Dr. Mehboob is with School of Biochemistry, Minhaj University Lahore in Lahore, Pakistan., Saleem M; Ms. Akram and Drs. Ali, Mutahir, and Saleem are with School of Biochemistry and Biotechnology, University of the Punjab in Lahore, Pakistan. |
المصدر: | Innovations in clinical neuroscience [Innov Clin Neurosci] 2023 Jan-Mar; Vol. 20 (1-3), pp. 60-71. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Matrix Medical Communications Country of Publication: United States NLM ID: 101549695 Publication Model: Print Cited Medium: Print ISSN: 2158-8333 (Print) Linking ISSN: 21588333 NLM ISO Abbreviation: Innov Clin Neurosci Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Publication: West Chester, Pennsylvania : Matrix Medical Communications Original Publication: [Edgemont, Pa.] : [Matrix Medical Communications], [2011]- |
مستخلص: | Objective: Gene-environment interactions might play a significant role in the development of bipolar disorder (BD). The objective of the current study was to investigate the association between tumor necrosis factor (TNF)-α -308 G/A polymorphism and BD and conduct a bioinformatics analysis of the protein-protein network of TNF-α. Gene-environment interactions and the relationship between stressful life events (SLEs) and substance abuse with TNF genotypes and other characteristics were analyzed. Methods: The genomic deoxyribonucleic acid (DNA) of 400 patients with BD and 200 control subjects were extracted and genotyped for TNF-α -308 G/A polymorphism. SLEs and substance abuse were evaluated using the Life Event and Difficulty Schedule (LEDS) and a self-designed substance abuse questionnaire for the events six months prior to the onset of the disease, respectively. Gene-environment interactions were assessed by multiple statistical tools. Bioinformatics analysis of the TNF-α network and its interacting proteins was carried out using STRING and Cytoscape softwares. Results: Genotyping analysis revealed a significant association between TNF-α -308 G/A polymorphism and BD ( p <0.009). Furthermore, analysis of gene-environment interaction revealed a significant association between TNF-α -308 G/A and SLEs ( p =0.001) and TNF-α -308 G/A and substance abuse ( p =0.001). Three distinct proteins, RELA, RIPK1, and BIRC3, were identified through hub analysis of the protein network. Conclusion: TNF-α -308 G/A polymorphism is positively associated with BD. SLEs and substance abuse might trigger the early onset of BD. Proteins identified through bioinformatics analysis might contribute to the TNF-α mediated pathophysiology of BD and can be the potential therapeutic targets. Competing Interests: DISCLOSURES: The authors have no conflicts of interest relevant to the contents of this article. (Copyright © 2023. Matrix Medical Communications. All rights reserved.) |
References: | Neuropsychiatr Dis Treat. 2017 Apr 12;13:1081-1088. (PMID: 28442912) Transl Psychiatry. 2018 Oct 11;8(1):217. (PMID: 30310056) Clin Exp Immunol. 2008 Feb;151(2):251-9. (PMID: 18062795) J Affect Disord. 2011 Dec;135(1-3):56-65. (PMID: 21439648) Front Psychiatry. 2018 May 23;9:200. (PMID: 29875708) Genome Biol. 2016 Nov 14;17(1):228. (PMID: 27842596) Mol Psychiatry. 2003 Aug;8(8):718-20. (PMID: 12888800) Neuropsychopharmacology. 2011 Aug;36(9):1921-31. (PMID: 21593732) Clin Pract Epidemiol Ment Health. 2018 Feb 28;14:37-45. (PMID: 29541150) Medicine (Baltimore). 2009 Nov;88(6):349-357. (PMID: 19910749) Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1355-61. (PMID: 18316149) Neuroscience. 2009 Nov 24;164(1):331-43. (PMID: 19358880) Int J Mol Sci. 2016 May 14;17(5):. (PMID: 27187381) BMC Syst Biol. 2014;8 Suppl 4:S11. (PMID: 25521941) Am J Psychiatry. 2001 Jun;158(6):885-91. (PMID: 11384895) J Allergy Clin Immunol. 2016 Oct;138(4):984-1010. (PMID: 27577879) Int J Bipolar Disord. 2015 Feb 25;3:6. (PMID: 25717427) Am J Geriatr Psychiatry. 2017 Jan;25(1):50-61. (PMID: 27840055) J Neuroinflammation. 2016 Jan 06;13:5. (PMID: 26732584) Am J Addict. 2018 Apr;27(3):188-201. (PMID: 29596721) Psychiatry Res. 2004 Jan 30;125(1):65-8. (PMID: 14967554) Biol Psychiatry. 2000 Sep 15;48(6):477-85. (PMID: 11018221) BMC Psychiatry. 2010 Jan 27;10:9. (PMID: 20105311) J Neural Transm (Vienna). 2015 Feb;122(2):307-20. (PMID: 24938371) Genes Immun. 2001 Aug;2(5):280-3. (PMID: 11528523) Front Public Health. 2016 Mar 24;4:49. (PMID: 27047914) Ther Adv Psychopharmacol. 2018 Apr 26;8(9):251-269. (PMID: 30181867) Curr Protoc Bioinformatics. 2014 Sep 08;47:8.13.1-24. (PMID: 25199793) Am J Psychiatry. 2005 Sep;162(9):1672-9. (PMID: 16135627) J Affect Disord. 2014 Jun;161:104-8. (PMID: 24751316) Schizophr Bull. 2017 Jul 1;43(4):881-890. (PMID: 28049760) Appl Clin Genet. 2014 Feb 12;7:33-42. (PMID: 24683306) Int J Neuropsychopharmacol. 2007 Aug;10(4):437-47. (PMID: 16756688) Psychol Med. 2013 Dec;43(12):2583-92. (PMID: 23419615) J Affect Disord. 2010 Sep;125(1-3):345-9. (PMID: 20172611) Psychiatry Res. 2017 Dec;258:434-437. (PMID: 28870645) Pharmacol Res. 2021 Jan;163:105325. (PMID: 33278569) Depress Anxiety. 2017 May;34(5):419-426. (PMID: 28102561) Int J Bipolar Disord. 2020 Jan 6;8(1):1. (PMID: 31903509) J Nerv Ment Dis. 2017 Mar;205(3):173-177. (PMID: 26785056) Transl Psychiatry. 2014 Jul 22;4:e412. (PMID: 25050992) Noro Psikiyatr Ars. 2019 Oct 23;57(2):136-140. (PMID: 32550780) Trends Mol Med. 2006 Dec;12(12):559-66. (PMID: 17070107) Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612. (PMID: 33237311) Eur Arch Psychiatry Clin Neurosci. 2011 Mar;261(2):139-43. (PMID: 20446090) Psychiatr Genet. 2000 Dec;10(4):195-8. (PMID: 11324946) J Affect Disord. 2007 Apr;99(1-3):37-44. (PMID: 17084905) BMC Public Health. 2016 Apr 14;16:333. (PMID: 27079787) Nat Rev Drug Discov. 2020 Aug;19(8):553-571. (PMID: 32669658) Front Psychol. 2015 Jun 09;6:779. (PMID: 26106354) Psychiatry Res. 2016 Oct 30;244:19-23. (PMID: 27455146) Depress Res Treat. 2012;2012:435486. (PMID: 22319647) J Clin Psychiatry. 2017 Feb;78(2):e152-e160. (PMID: 28234432) Nucleic Acids Res. 2000 Jan 1;28(1):27-30. (PMID: 10592173) Front Psychiatry. 2020 Feb 26;11:71. (PMID: 32174850) Psychiatry Investig. 2016 Jan;13(1):18-33. (PMID: 26766943) Compr Psychiatry. 2019 Apr;90:82-87. (PMID: 30782515) Psychiatry Res. 2017 Jul;253:338-350. (PMID: 28419959) Psychiatry Res. 2016 Sep 30;243:225-231. (PMID: 27423121) Neural Plast. 2014;2014:360481. (PMID: 25313338) Clin Psychopharmacol Neurosci. 2017 Aug 31;15(3):269-275. (PMID: 28783937) Indian J Psychol Med. 2019 Jan-Feb;41(1):61-67. (PMID: 30783310) Neuropsychobiology. 2008;57(1-2):88-94. (PMID: 18515978) Neuroscience. 2015 Aug 27;302:2-22. (PMID: 26117714) CNS Spectr. 2009 Aug;14(8):419-25. (PMID: 19890236) J Affect Disord. 2016 Mar 15;193:89-93. (PMID: 26771949) J Affect Disord. 2014 Jun;161:55-64. (PMID: 24751308) Lancet. 2020 Dec 5;396(10265):1841-1856. (PMID: 33278937) Clin Neuropharmacol. 2012 Sep-Oct;35(5):235-43. (PMID: 22986797) Gac Med Mex. 2017 Mar - Apr;153(2):238-250. (PMID: 28474710) |
فهرسة مساهمة: | Keywords: Bipolar disorder; TNF-α; inflammation; polymorphism; stressful life event |
تواريخ الأحداث: | Date Created: 20230501 Latest Revision: 20231031 |
رمز التحديث: | 20231101 |
مُعرف محوري في PubMed: | PMC10132278 |
PMID: | 37122575 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2158-8333 |
---|